![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, March 05, 2010 8:06:25 AM
Quest Licenses Another Epigenomics Biomarker
February 25, 2009
By a GenomeWeb staff reporter
Type size:
-
+EmailPrinter-friendly versionRSS FeedNEW YORK (GenomeWeb News) — Quest Diagnostics has licensed a biomarker for prostate cancer from Epigenomics, which it plans to use to develop a molecular diagnostic test for diagnosing the disease, Epigenomics said today.
The agreement gives Quest the rights to use the GSTP1 DNA methylation biomarker in order to both develop and market the diagnostic test, which will be performed using patient tissue samples.
Quest licensed the rights to an Epigenomics biomarker for colorectal cancer in 2008 in order to develop a test to help detect that disease.
Financial terms of the agreement were not released.
The clinical lab giant has experience in developing DNA methylation diagnostic tests. It currently offers two such tests, one for Prader-Willi syndrome and one for Angelman syndrome, both of which are neurological epigenetic disorders that may be caused by faulty DNA methylation.
http://www.genomeweb.com/node/912354?emc=el&m=319663&l=1&v=277640021d
I'll drop off the kids and see what else I can find
Recent HDVY News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 07:50:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 07:10:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 09:13:54 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM